Axhidrox (glycopyrronium bromide) pump-pack 2.2 mg/pump actuation cream

Axhidrox is indicated for the topical treatment of severe primary axillary
hyperhidrosis in adults.

Axhidrox received a UK marketing authorisation in June 2025 and further information on the availability of Axhidrox will be available soon.

The Summary of Product Characteristics can be viewed here.